Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
106,558,416
-
Share change
-
+297,750
-
Total reported value
-
$154,507,811
-
Put/Call ratio
-
6.1%
-
Price per share
-
$1.45
-
Number of holders
-
109
-
Value change
-
+$571,013
-
Number of buys
-
52
-
Number of sells
-
36
Institutional Holders of RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) as of Q4 2023
As of 31 Dec 2023,
RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
106,558,416 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., MORGAN STANLEY, Soleus Capital Management, L.P., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, and Nuveen Asset Management, LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.